Genmab A/S (FRA:GE9)
Germany · Delayed Price · Currency is EUR 272.60
-2.80 (-1.02%)
At close: Jan 30, 2026
Genmab Market Cap
Genmab has a market cap or net worth of €16.68 billion as of January 30, 2026. Its market cap has increased by 24.47% in one year.
Market Cap
16.68B
Enterprise Value
13.89B
Revenue
3.28B
Ranking
n/a
PE Ratio
12.36
Stock Price
€272.60
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 485.53M to 16.68B, an increase of 3,334.85%. That is a compound annual growth rate of 15.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 16.68B | -0.25% |
| Dec 30, 2025 | 16.72B | 31.47% |
| Dec 30, 2024 | 12.72B | -32.67% |
| Dec 29, 2023 | 18.89B | -26.92% |
| Dec 30, 2022 | 25.84B | 11.67% |
| Dec 30, 2021 | 23.14B | 6.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.59B |
| Siemens Healthineers AG | 47.05B |
| Bayer Aktiengesellschaft | 43.78B |
| Fresenius SE & Co. KGaA | 26.59B |
| Sartorius Aktiengesellschaft | 14.69B |
| Fresenius Medical Care AG | 10.52B |
| Fielmann Group AG | 3.48B |
| Carl Zeiss Meditec AG | 2.45B |